Immune Health

Immune System Restoration Stack

This stack addresses immune dysfunction at three levels: T-cell regulation (Thymosin Alpha-1), systemic inflammation and tissue repair (TB-500), and gut-mucosal immune foundation (BPC-157). Thymosin Alpha-1 is the most clinically validated immune peptide available, approved in 37 countries for chronic hepatitis and immune compromise — it strengthens immune response without inflammatory overshoot. Together, the three compounds rebuild immune competence from the cellular, inflammatory, and gut-axis levels — not just temporarily stimulate it.

Intermediate 8 week cycle 3 peptides Save
For educational and research purposes only. Not medical advice. This protocol describes research use, not human administration. Always consult a qualified professional.

Protocol & Dosing

Loading Phase (Weeks 1–2):

  • Thymosin Alpha-1: 1.5 mg subcutaneously twice weekly
  • TB-500: 5 mg subcutaneously twice weekly
  • BPC-157: 500 mcg subcutaneously or orally daily
Maintenance Phase (Weeks 3–8):
  • Thymosin Alpha-1: 1.5 mg subcutaneously once weekly
  • TB-500: 2.5 mg subcutaneously once weekly
  • BPC-157: 250 mcg subcutaneously daily
Cycle: 8 weeks on / 4 weeks off

Notes: TA-1 can be continued beyond 8 weeks at maintenance dose during active illness or immune compromise. BPC-157 can be taken orally (mixed in water) if injections are not practical — oral BPC-157 has documented GI tract bioavailability. Support with a quality probiotic throughout the cycle.

Calculate Doses for This Stack

Use the Peptide Oracle calculator to get exact BAC water ratios and draw amounts for every peptide in this protocol.

Open Dosage Calculator